DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Spirapril
Spirapril
Supplementary Appendix 1. Search Strategy for the Systematic Review and Meta-Analysis
"Coaprovel, INN-Irbesartan+Hydrochlorothiazide"
Hypertension and Cardiac Arrhythmias: a Review of the Epidemiology, Pathophysiology and Clinical Implications
“Captopril” [Mesh
Effects of Captopril and Losartan on Thermal and Chemical Induced Pain in Mice
RAS) System ______30.04.2014 | Circular Number P09/2014
Trends and Pattern of the Utilization of Cardiovascular Medicines in Lithuania in 2003–2012
Combined Use of Medicines Affecting the Renin-Angiotensin System (RAS) to Be Restricted – CHMP Endorses PRAC Recommendation EMA/294911/2014 Page 2/4
Spirapril Hydrochloride | Medchemexpress
Telmisartan Versus Angiotension-Converting
Supplementary Information
ACE-Inhibitor Therapy with Spirapril Increases Nocturnal Hypotensive Episodes in Elderly Hypertensive Patients
The Potential Therapeutic Use of Reninangiotensin System Inhibitors
List Item Renin-Angiotensin-System
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Combination of Angiotensin Converting Enzyme Inhibitors and All Antagonists
Top View
KDIGO-2021-BP-GL.Pdf
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Angiotensin-Converting Enzyme Inhibitors
Carrier59.Pdf
Download Surveillance Report [PDF · 1.1
Does Chinese Ethnicity Affect the Pharmacokinetics and Pharmacodynamics of Angiotensin-Converting Enzyme Inhibitors?
Agreed Core Safety Profile
An Application to Include Blood Pressure Lowering Drug Fixed Dose
Baltic Statistics on Medicines 2010–2012 2 | Sales Statistics 2010–2012 Sales Statistics 2010–2012 |
Comparative Effects of Losartan and Enalapril on Serum Digoxin Levels in Patients with Congestive Heart Failure
Empirical Evidence from a Panel of Italian Patients
Resolution Ap (2000) 1
Czech and Slovak Spirapril Intervention Study (CASSIS)
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Supplementary Materials